Akorn to Acquire Hi-Tech Pharmacal for $640M in Cash, $43.50/Share

By: Benzinga
Akorn, Inc. (NASDAQ: AKRX ) and Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK ) today announced that they have entered into a definitive agreement under which Akorn will acquire Hi-Tech for $640 million in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.